Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay M Sosenko

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Current Diabetes Reports|December 4, 2009
The prevalence of diabetic neuropathy according to ethnicityJay M Sosenko
Current Opinion in Endocrinology, Diabetes, and Obesity|July 1, 2016
Staging the progression to type 1 diabetes with prediagnostic markersJay M Sosenko
JAMA|June 20, 2013
The evolution of type 1 diabetesJay S Skyler, Jay M Sosenko
Diabetes|March 20, 2026
Predicting the Timing of the Metabolic Inflection Point in Type 1 Diabetes Progression Using Machine Learning and Survival Analysis ModelsEslam Montaser, Jay M Sosenko, Heba M Ismail
Clinical Diabetes : a Publication of the American Diabetes Association|February 28, 2022
Do-It-Yourself Diabetes Management: Perspectives of a Patient, a Physician, and an EthicistKaren Dimentstein, Jay M Sosenko, Kenneth W Goodman
Diabetes Care|June 29, 2004
Sensory function and albumin excretion according to diagnostic criteria for diabetesJay M Sosenko, Martha Kato, Ronald B Goldberg
Current Diabetes Reports|June 17, 2015
The development, validation, and utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS)Jay M Sosenko, Jay S Skyler, Jerry P Palmer, et al.
Diabetes|September 23, 2021
The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 DiabetesEmily K Sims, David Cuthbertson, Kevan C Herold, et al.
Diabetes|May 24, 2012
The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1Jay M Sosenko, Jay S Skyler, Kevan C Herold, et al.
Diabetes|December 24, 2009
Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onsetEle Ferrannini, Andrea Mari, Valentina Nofrate, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Current Diabetes Reports|December 4, 2009
The prevalence of diabetic neuropathy according to ethnicityJay M Sosenko
Current Opinion in Endocrinology, Diabetes, and Obesity|July 1, 2016
Staging the progression to type 1 diabetes with prediagnostic markersJay M Sosenko
JAMA|June 20, 2013
The evolution of type 1 diabetesJay S Skyler, Jay M Sosenko
Diabetes|March 20, 2026
Predicting the Timing of the Metabolic Inflection Point in Type 1 Diabetes Progression Using Machine Learning and Survival Analysis ModelsEslam Montaser, Jay M Sosenko, Heba M Ismail
Clinical Diabetes : a Publication of the American Diabetes Association|February 28, 2022
Do-It-Yourself Diabetes Management: Perspectives of a Patient, a Physician, and an EthicistKaren Dimentstein, Jay M Sosenko, Kenneth W Goodman
Diabetes Care|June 29, 2004
Sensory function and albumin excretion according to diagnostic criteria for diabetesJay M Sosenko, Martha Kato, Ronald B Goldberg
Current Diabetes Reports|June 17, 2015
The development, validation, and utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS)Jay M Sosenko, Jay S Skyler, Jerry P Palmer, et al.
Diabetes|September 23, 2021
The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 DiabetesEmily K Sims, David Cuthbertson, Kevan C Herold, et al.
Diabetes|May 24, 2012
The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1Jay M Sosenko, Jay S Skyler, Kevan C Herold, et al.
Diabetes|December 24, 2009
Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onsetEle Ferrannini, Andrea Mari, Valentina Nofrate, et al.
Pageof 8